Structural recognition and functional activation of FcγR by innate pentraxins

Nature

Volumn 456, Issue 7224, 2008, Pages 989-992

  Lu, Jinghua ^a   Marnell, Lorraine L ^b   Marjon, Kristopher D ^b   Mold, Carolyn ^b   Du Clos, Terry W ^b,c   Sun, Peter D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIA; IMMUNOGLOBULIN G; SERUM AMYLOID P;

ANTIBODY; DISEASE TREATMENT; HOMINID; IMMUNE RESPONSE; INHIBITION; MICROORGANISM; MUTATION; PATHOGEN; PROTEIN; SECRETION; SERUM; STOICHIOMETRY;

ADAPTIVE IMMUNITY; ARTICLE; BINDING SITE; CAPPING PHENOMENON; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; STOICHIOMETRY;

BINDING SITES; BINDING, COMPETITIVE; C-REACTIVE PROTEIN; CRYSTALLOGRAPHY, X-RAY; CYTOKINES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; MACROPHAGES; MODELS, MOLECULAR; PHAGOCYTOSIS; PROTEIN CONFORMATION; RECEPTORS, IGG; SERUM AMYLOID P-COMPONENT;

EID: 57749172475     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature07468     Document Type: Article

References (41)

1. Steel, D. M. & Whitehead, A. S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15, 81-88 (1994).
2. Pepys, M. B. et al. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32, 119-124 (1978).
3. Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu. Rev. Immunol. 23, 337-366 (2005).
4. Kaplan, M. H. & Volanakis, J. E. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112, 2135-2147 (1974).
5. Bharadwaj, D., Stein, M. P., Volzer, M., Mold, C. & Du Clos, T. W. The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J. Exp. Med. 190, 585-590 (1999).
6. Marnell, L. L., Mold, C., Volzer, M. A., Burlingame, R. W. & Du Clos, T. W. C-reactive protein binds to FcγRI in transfected COS cells. J. Immunol. 155, 2185-2193 (1995).
7. Bodman-Smith, K. B. et al. C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI). Immunology 107, 252-260 (2002).
8. Bharadwaj, D., Mold, C., Markham, E. & Du Clos, T. W. Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis. J. Immunol. 166, 6735-6741 (2001).
9. Alles, V. V. et al. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84, 3483-3493 (1994).
10. Han, B. et al. TNFα-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J. Immunol. 175, 8303-8311 (2005).
11. Ravetch, J. V. & Bolland, S. IgGFc receptors.Annu. Rev. Immunol. 19, 275-290 (2001).
12. Bickerstaff,M. C. et al. Serumamyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med. 5, 694-697 (1999).
13. Xia, D. & Samols, D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl Acad. Sci. USA 94, 2575-2580 (1997).
14. Mold, C., Rodriguez, W., Rodic-Polic, B. & Du Clos, T. W. C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR. J. Immunol. 169, 7019-7025 (2002).
15. Emsley, J. et al. Structure of pentameric human serum amyloid P component. Nature 367, 338-345 (1994).
16. Maxwell, K. F. et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nature Struct. Biol. 6, 437-442 (1999).
17. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
18. Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G. & Sun, P. D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405, 537-543 (2000).
19. Ysern, X., Li, H. & Mariuzza, R. A. Imperfect interfaces. Nature Struct. Biol. 5, 412-414 (1998).
20. Hulett, M. D. & Hogarth, P. M. Molecular basis of Fc receptor function. Adv. Immunol. 57, 1-127 (1994).
21. Shrive, A. K. et al. Three dimensional structure of human C-reactive protein. Nature Struct. Biol. 3, 346-354 (1996).
22. Thompson, D., Pepys, M. B. & Wood, S. P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7, 169-177 (1999).
23. Bang,R. et al.Analysis ofbinding sites inhuman C-reactive protein for FcγRI, FcγRIIA, and C1q by site-directed mutagenesis. J. Biol. Chem. 280, 25095-25102 (2005).
24. Tax, W. J., Willems, H. W., Reekers, P. P., Capel, P. J. & Koene, R. A. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304, 445-447 (1983).
25. Clark, M. R., Stuart, S. G., Kimberly, R. P., Ory, P. A. & Goldstein, I. M. A single amino acid distinguishes the high-responder from the low-responder form of Fc receptor II on human monocytes. Eur. J. Immunol. 21, 1911-1916 (1991).
26. Parren, P. W. et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 90, 1537-1546 (1992).
27. Stein, M. P. et al. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific. J. Clin. Invest. 105, 369-376 (2000).
28. Radaev, S., Motyka, S., Fridman, W. H., Sautes-Fridman, C. & Sun, P. D. The structure of a human type III Fcγ receptor in complex with Fc. J. Biol. Chem. 276, 16469-16477 (2001).
29. Mold, C., Baca, R. & Du Clos, T. W. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcg receptors. J. Autoimmun. 19, 147-154 (2002).
30. Mold, C. & Du Clos, T. W. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fcγ receptors. J. Immunol. 176, 7598-7604 (2006).
31. Sondermann, P. & Jacob, U. Human Fcγ receptor IIb expressed in Escherichia coli reveals IgG binding capability. Biol. Chem. 380, 717-721 (1999).
32. Du Clos, T. W. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143, 2553-2559 (1989).
33. Potempa, L. A., Siegel, J. N., Fiedel, B. A., Potempa, R. T. & Gewurz, H. Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol. Immunol. 24, 531-541 (1987).
34. Otwinowski, Z. M. W. processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
35. Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D 57, 1373-1382 (2001).
36. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
37. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
38. Brunger, A. T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr.D54, 905-921 (1998).
39. Snyder, G. A., Brooks, A. G. & Sun, P. D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc. Natl Acad. Sci. USA 96, 3864-3869 (1999).
40. Mustard, D. & Ritchie, D. W. Docking essential dynamics eigenstructures. Proteins 60, 269-274 (2005).
41. Delano, W. L. The PyMOL Molecular Graphics System 〈http://www.pymol.org〉 (2002).